医学
禁忌症
肝移植
移植
化疗
存活率
胃肠病学
外科
内科学
肝病
病理
替代医学
作者
Morten Hagness,Aksel Foss,Pål‐Dag Line,Tim Scholz,P. Jørgensen,Bjarte Fosby,Kirsten Muri Boberg,Øystein Mathisen,Ivar P. Gladhaug,T Egge,Steinar Solberg,John Hausken,Svein Dueland
出处
期刊：Annals of Surgery
[Lippincott Williams & Wilkins]
日期：2013-01-29
卷期号：257 (5): 800-806
被引量：414
标识
DOI：10.1097/sla.0b013e3182823957
摘要
OS exceeds by far reported outcome for chemotherapy, which is the only treatment option available for this patient group. Furthermore, OS is comparable with liver resection for resectable CLMs and survival after repeat liver transplantation for nonmalignant diseases. Selection strategies based on prognostic factors may further improve the outcome (ClinicalTrials.gov: NCT01311453).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
OsamaKareem
风声3492881045
Twonej
科研狗
干净的琦
殷勤的紫槐
Nexus
张欢馨
GingerF
8R60d8
贪玩的秋柔
AllRightReserved
蓝天
sinmon
godblessyou
学术文献互助
xiaolizi
畔畔
整齐的凌兰
皖公网安备34019202002308
